CONSUN PHARMACEUTICAL GRP LIMITED revenue breakdown overview

CONSUN PHARMACEUTICAL GRP LIMITED revenue for the last year amounted to 3.16 B HKD, the most of which — 2.74 B HKD — came from its highest performing source at the moment, Consun Pharmaceutical, the year earlier bringing 2.43 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought CONSUN PHARMACEUTICAL GRP LIMITED 3.22 B HKD, and the year before that — 2.86 B HKD.